Photocages Made to Order: Late-Stage Caging Protocol Enables Anti-Cancer Control with Near-Infrared Light

Peter Stacko,Marina Russo,Andrea Ramundo,Dominika Zielinska,Katarzyna Hanc,Delia Meier,Attila Szabo
DOI: https://doi.org/10.26434/chemrxiv-2024-2t8hw
2024-07-24
Abstract:Nature has perfected the reversible control over the activity of molecules and biomolecules in the human body. Photocages aim to mimic this control in space and time using light as a trigger, and the field has witnessed many excellent contributions that extend their use to the tissue-penetrating region. Yet little attention has been paid to developing simple caging strategies which are crucial to translate photocages into a widely accepted tool beyond chemical space. Here, we report a robust and user-friendly protocol that enables installation of amine, thiol and phenol payloads in a single step under mild conditions and using bench-stable intermediates. The protocol displays excellent compatibility with payloads, manifested by caging hormones, neurotransmitters, a tripeptide and many highly complex FDA-approved drugs, including antibiotics or anti-cancer agents. In a proof-of-concept study, we utilize this strategy to cage the clinically used CDK4/6 inhibitor palbociclib and control the activity of the tumor suppressing retinoblastoma protein in human breast cancer cells by near-infrared (NIR) light. We anticipate that normalizing the access to NIR-absorbing photocages through this protocol will empower research across various scientific disciplines.
Chemistry
What problem does this paper attempt to address?